Introduction to AMVUTTRA™ (vutrisiran)

Date/Time: Monday, October 24, 2022 - 6:00 AM – 7:00 AM
Track: Satellite Symposium
Room: Grand Ballroom A
Log in to Add to My Schedule


Join our distinguished faculty as he discusses recognizing, diagnosing, and managing adult patients with polyneuropathy caused by hereditary transthyretin-mediated (hATTR) amyloidosis. He will provide an overview of hATTR amyloidosis and review the clinical profile of AMVUTTRA, a new treatment for the polyneuropathy of hATTR amyloidosis in adults.

Sponsored by: Alnylam via CM Group